A six‐month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia
Open Access
- 31 January 2008
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 58 (2) , 612-622
- https://doi.org/10.1002/art.23203
Abstract
Objective A subset of fibromyalgia (FM) patients have a dysfunctional hypothalamic–pituitary–insulin‐like growth factor 1 (IGF‐1) axis, as evidenced by low serum levels of IGF‐1 and a reduced growth hormone (GH) response to physiologic stimuli. There is evidence that pyridostigmine (PYD) improves the acute response of GH to exercise in FM patients. The purpose of this study was to evaluate the clinical effectiveness of 6 months of PYD and group exercise on FM symptoms. Methods FM patients were randomized to 1 of the following 4 groups: PYD plus exercise, PYD plus diet recall but no exercise, placebo plus exercise, and placebo plus diet recall but no exercise. The primary outcome measures were the visual analog scale (VAS) score for pain, tender point count, and total myalgic score. Secondary outcome measures were the total score on the Fibromyalgia Impact Questionnaire (FIQ) and FIQ VAS scores for individual symptoms (fatigue, poor sleep, stiffness, and anxiety), as well as quality of life (QOL) and physical fitness (lower body strength/endurance, upper and lower body flexibility, balance, and time on the treadmill). Results A total of 165 FM patients completed baseline measurements; 154 (93.3%) completed the study. The combination of PYD and exercise did not improve pain scores. PYD groups showed a significant improvement in sleep and anxiety in those who completed the study and in QOL in those who complied with the therapeutic regimen as compared with the placebo groups. Compared with the nonexercise groups, the 2 exercise groups demonstrated improvement in fatigue and fitness. PYD was generally well tolerated. Conclusion Neither the combination of PYD plus supervised exercise nor either treatment alone yielded improvement in most FM symptoms. However, PYD did improve anxiety and sleep, and exercise improved fatigue and fitness. We speculate that PYD may have improved vagal tone, thus benefiting sleep and anxiety; this notion warrants further study.Keywords
This publication has 46 references indexed in Scilit:
- Effect of acetylcholinesterase inhibition with pyridostigmine on cardiac parasympathetic function in sedentary adults and trained athletesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- An internet survey of 2,596 people with fibromyalgiaBMC Musculoskeletal Disorders, 2007
- A Pilot Study of the Efficacy of Heart Rate Variability (HRV) Biofeedback in Patients with FibromyalgiaApplied Psychophysiology and Biofeedback, 2007
- Muscle hypertrophy, strength development, and serum hormones during strength training in elderly women with fibromyalgiaScandinavian Journal of Rheumatology, 2005
- Acetylcholinesterase Inhibition Improves Tachycardia in Postural Tachycardia SyndromeCirculation, 2005
- Eight weeks of moderate-intensity exercise training increases heart rate variability in sedentary postmenopausal womenAmerican Heart Journal, 2004
- Involvement of Endogenous Growth Hormone-Releasing Hormone (GHRH) in the Exercise-Related Response of Growth HormoneInternational Journal of Sports Medicine, 2003
- Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluationPublished by Elsevier ,2002
- The american college of rheumatology 1990 criteria for the classification of fibromyalgiaArthritis & Rheumatism, 1990
- A research approach to improving our quality of life.American Psychologist, 1978